Mechanisms of human autoimmunity

被引:330
作者
Rosenblum, Michael D.
Remedios, Kelly A.
Abbas, Abul K. [1 ]
机构
[1] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
关键词
REGULATORY T-CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; IMMUNE DYSREGULATION; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; INTERLEUKIN-2; DISEASE; MUTATIONS; PSORIASIS; INFLAMMATION;
D O I
10.1172/JCI78088
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Autoimmune reactions reflect an-imbalance between effector and regulatory immune responses, typically develop through stages of initiation and propagation, and often show phases of resolution (indicated by clinical remissions) and exacerbations (indicated by symptomatic flares). The fundamental underlying mechanism of autoimmunity is defective elimination and/or control of self-reactive lymphocytes. Studies in humans and experimental animal models are revealing the genetic and environmental factors that contribute to autoimmunity. A major goal of research in this area is to exploit this knowledge to better understand the pathogenesis of autoimmune diseases and-to develop strategies for reestablishing the normal balance between effector and regulatory immune responses.
引用
收藏
页码:2228 / 2233
页数:6
相关论文
共 57 条
[1]   An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains [J].
Aaltonen, J ;
Bjorses, P ;
Perheentupa, J ;
HorelliKuitunen, N ;
Palotie, A ;
Peltonen, L ;
Lee, YS ;
Francis, F ;
Hennig, S ;
Thiel, C ;
Lehrach, H ;
Yaspo, ML .
NATURE GENETICS, 1997, 17 (04) :399-403
[2]  
[Anonymous], BLOOD, DOI DOI 10.1182/BLOOD-2010-10-311894
[3]   Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial [J].
Baeten, Dominique ;
Baraliakos, Xenofon ;
Braun, Juergen ;
Sieper, Joachim ;
Emery, Paul ;
van der Heijde, Desiree ;
McInnes, Iain ;
van Laar, Jacob M. ;
Landewe, Robert ;
Wordsworth, Paul ;
Wollenhaupt, Juergen ;
Kellner, Herbert ;
Paramarta, Jacqueline ;
Wei, Jiawei ;
Brachat, Arndt ;
Bek, Stephan ;
Laurent, Didier ;
Li, Yali ;
Wang, Ying A. ;
Bertolino, Arthur P. ;
Gsteiger, Sandro ;
Wright, Andrew M. ;
Hueber, Wolfgang .
LANCET, 2013, 382 (9906) :1705-1713
[4]   Type I interferon in systemic lupus erythematosus and other autoimmune diseases [J].
Banchereau, Jacques ;
Pascual, Virginia .
IMMUNITY, 2006, 25 (03) :383-392
[5]   Role of the Microbiota in Immunity and Inflammation [J].
Belkaid, Yasmine ;
Hand, Timothy W. .
CELL, 2014, 157 (01) :121-141
[6]   The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 [J].
Bennett, CL ;
Christie, J ;
Ramsdell, F ;
Brunkow, ME ;
Ferguson, PJ ;
Whitesell, L ;
Kelly, TE ;
Saulsbury, FT ;
Chance, PF ;
Ochs, HD .
NATURE GENETICS, 2001, 27 (01) :20-21
[7]   T Regulatory Cells in Autoimmune Diabetes: Past Challenges, Future Prospects [J].
Bluestone, Jeffrey A. ;
Tang, Qizhi ;
Sedwick, Caitlin E. .
JOURNAL OF CLINICAL IMMUNOLOGY, 2008, 28 (06) :677-684
[8]   Foxp3+Regulatory T Cells of Psoriasis Patients Easily Differentiate into IL-17A-Producing Cells and Are Found in Lesional Skin [J].
Bovenschen, H. Jorn ;
van de Kerkhof, Peter C. ;
van Erp, Piet E. ;
Woestenenk, Rob ;
Joosten, Irma ;
Koenen, Hans J. P. M. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (09) :1853-1860
[9]   Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-α [J].
Boyman, O ;
Hefti, HP ;
Conrad, C ;
Nickoloff, BJ ;
Suter, M ;
Nestle, FO .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (05) :731-736
[10]   Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases [J].
Buckner, Jane Hoyt .
NATURE REVIEWS IMMUNOLOGY, 2010, 10 (12) :849-859